These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26590327)

  • 1. Identification of potential transmembrane protease serine 4 inhibitors as anti-cancer agents by integrated computational approach.
    Ilamathi M; Hemanth R; Nishanth S; Sivaramakrishnan V
    J Theor Biol; 2016 Jan; 389():253-62. PubMed ID: 26590327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of the structural requirements of HIV-protease inhibitors using pharmacophore, virtual screening and molecular docking approaches for lead identification.
    Islam MA; Pillay TS
    J Mol Graph Model; 2015 Mar; 56():20-30. PubMed ID: 25541527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploration of New and Potent Lead Molecules Against CAAX Prenyl Protease I of Leishmania donovani Through Pharmacophore Based Virtual Screening Approach.
    Prabhu SV; Tiwari K; Suryanarayanan V; Dubey VK; Singh SK
    Comb Chem High Throughput Screen; 2017; 20(3):255-271. PubMed ID: 28116998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
    Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
    J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based discovery of small molecule hepsin and HGFA protease inhibitors: Evaluation of potency and selectivity derived from distinct binding pockets.
    Franco FM; Jones DE; Harris PK; Han Z; Wildman SA; Jarvis CM; Janetka JW
    Bioorg Med Chem; 2015 May; 23(10):2328-43. PubMed ID: 25882520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of novel chemical scaffolds targeting prolyl oligopeptidase for neurological therapeutics.
    Kumar R; Parameswaran S; Bavi R; Baek A; Son M; Rampogu S; Park C; Lee G; Zeb A; Parate S; Rana RM; Lee KW
    J Mol Graph Model; 2019 May; 88():92-103. PubMed ID: 30665156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designing of potential inhibitors against Staphylococcus aureus sortase A: Combined analogue and structure based approach with in vitro validation.
    Raj KK; Ganesh Kumar V; Leela Madhuri C; Mathi P; Durga Lakshmi R; Ravi M; Sri Ramudu B; Venkata Rao SV; Ramachandran D
    J Mol Graph Model; 2015 Jul; 60():89-97. PubMed ID: 26119984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel inhibitor of dengue virus protease through use of a virtual screening drug discovery Web portal.
    Viswanathan U; Tomlinson SM; Fonner JM; Mock SA; Watowich SJ
    J Chem Inf Model; 2014 Oct; 54(10):2816-25. PubMed ID: 25263519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
    Kesharwani RK; Singh DV; Misra K
    J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TMPRSS13, a type II transmembrane serine protease, is inhibited by hepatocyte growth factor activator inhibitor type 1 and activates pro-hepatocyte growth factor.
    Hashimoto T; Kato M; Shimomura T; Kitamura N
    FEBS J; 2010 Dec; 277(23):4888-900. PubMed ID: 20977675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovering best candidates for Hepatocellular Carcinoma (HCC) by in-silico techniques and tools.
    Mabrouk MS
    Int J Bioinform Res Appl; 2012; 8(1-2):141-52. PubMed ID: 22450276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
    Davis GD; Vasanthi AH
    Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Pak1 inhibitors using water thermodynamic analysis.
    Biswal J; Jayaprakash P; Suresh Kumar R; Venkatraman G; Poopandi S; Rangasamy R; Jeyaraman J
    J Biomol Struct Dyn; 2020 Jan; 38(1):13-31. PubMed ID: 30661460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular docking and 3D-QSAR-based virtual screening of flavonoids as potential aromatase inhibitors against estrogen-dependent breast cancer.
    Awasthi M; Singh S; Pandey VP; Dwivedi UN
    J Biomol Struct Dyn; 2015; 33(4):804-19. PubMed ID: 24702656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening approaches against claudin-4 focusing on therapeutics through molecular docking and the analysis of their relative dynamics: a theoretical approach.
    Rambabu M; Jayanthi S
    J Recept Signal Transduct Res; 2020 Oct; 40(5):436-441. PubMed ID: 32321343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing and optimization of novel human LMTK3 inhibitors against breast cancer - a computational approach.
    Anbarasu K; Jayanthi S
    J Recept Signal Transduct Res; 2017 Feb; 37(1):51-59. PubMed ID: 27056562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational design of new protein kinase D 1 (PKD1) inhibitors: homology-based active site prediction, energy-optimized pharmacophore, docking and database screening.
    Nalini ; Chadha N; Bahia MS; Kaur M; Bahadur R; Silakari O
    Mol Divers; 2018 Feb; 22(1):47-56. PubMed ID: 29058231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular models of NS3 protease variants of the Hepatitis C virus.
    da Silveira NJ; Arcuri HA; Bonalumi CE; de Souza FP; Mello IM; Rahal P; Pinho JR; de Azevedo WF
    BMC Struct Biol; 2005 Jan; 5():1. PubMed ID: 15663787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel and potent inhibitors of the type II transmembrane serine protease, matriptase, based upon the sunflower trypsin inhibitor-1.
    Li P; Jiang S; Lee SL; Lin CY; Johnson MD; Dickson RB; Michejda CJ; Roller PP
    J Med Chem; 2007 Nov; 50(24):5976-83. PubMed ID: 17985858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.